| Financial Year |
March 31 2023 |
| Monetary Funds |
3,395,311,534.69 |
| Held-for-trading Financial Assets |
367,019.12 |
| Notes Receivable |
431,878.19 |
| Accounts Receivable |
272,818,720.66 |
| Advances to Suppliers |
1,172,586,758.54 |
| Other Receivables |
160,291,413.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,715,571.26 |
| Dividend Receivable |
-- |
| Inventories |
67,799,033.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
280,597,091.58 |
| Other Current Assets |
191,276,720.49 |
| Total Current Assets |
5,545,705,380.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,319,634,505.90 |
| Long-term Equity Investment |
615,034,728.21 |
| Investment Properties |
13,520,363.21 |
| Fixed Assetes |
664,316,924.77 |
| Under-construction Projects |
51,117,921.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,568,492,579.98 |
| R&D expenses |
-- |
| Goodwill |
7,582,674.49 |
| Long-Term Deferred and Prepaid Expenses |
29,813,292.87 |
| Deferred Income Tax Assets |
36,664,551.29 |
| Other Non-Current Assets |
235,116,170.26 |
| Sub-Total of Non-Current Assets |
36,776,827,926.78 |
| Total Assets |
42,322,533,307.43 |
| Short-Term Loans |
310,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,070,185,044.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
167,543,138.82 |
| Taxes Payable |
178,223,295.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
402,128,426.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,682,247,133.66 |
| Other Current Liabilities |
89,370,927.22 |
| Sub-Total of Current Liabilities |
3,949,723,703.13 |
| Long-term Loans |
17,545,493,200.23 |
| Bonds Payable |
1,290,000,000.00 |
| Long-Term Accounts Payable |
1,819,600.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,062,562.73 |
| Deferred Income Tax Liabilities |
3,482,241.08 |
| Other Non-Current Liabilities |
12,581,989.45 |
| Sub-Total of Non-Current Liabilities |
19,185,612,200.23 |
| Total Liabilities |
23,135,335,903.36 |
| Paid-In Capital(Or Share Stock) |
3,058,060,000.00 |
| Capital Surplus |
1,850,352,226.19 |
| Surplus Reserve |
7,270,482,444.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,056,298,177.07 |
| Minority Stockholder's Interest |
946,229,038.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,240,968,365.36 |
| Owner's Equity（Stockholder's Equity） |
19,187,197,404.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,322,533,307.43 |
